Gamma Guild Webinar Series 2021
Breast Cancer, Nuclear Medicine and PET
Tuesday 24 August 6:30pm AEST
Research in BreastScreen: a review of two recent projects
Michelle Clemson, Program Manager, Maroondah BreastScreen
Michelle Clemson has been the Program Manager, Maroondah BreastScreen, Eastern Health for nearly 9 years. During that time the Service has been involved in a number of research projects including being the first BreastScreen Service in the Australia to introduce tomosynthesis (3D mammography) in the Assessment Setting and Screening Setting.
Prior to joining the team at BreastScreen, Michelle was the Manager, Office for Research, Melbourne Health and undertook research at the Howard Florey Institute, The University of Melbourne, including completing a Visiting Researcher role at Edinburgh University, Scotland. Michelle has 10 published papers with the most recent publication in MJA for the tomosynthesis in screening project.
Michelle will be talking about results from two recent research projects:
1. First Australian Pilot Trial of Digital Breast Tomosynthesis; and
2. A pre-implementation study to understand women’s knowledge of the alcohol-breast cancer link, and acceptability of alcohol brief intervention in the breast screen setting
Wednesday 1 September 6:30pm AEST
The Role of Imaging in the Diagnosis and Staging of Breast Cancer: Where does PET/CT fit in?
Dr Kate Moodie, Radiologist and NM Physician, Peter MacCallum Cancer Centre
Dr Kate Moodie is a Radiologist and Nuclear Medicine Specialist at Peter MacCallum Cancer Centre in Melbourne. Her main speciality interest is breast imaging, including mammography, ultrasound, CT, MRI and PET-CT. She chairs the imaging for the Advanced Breast MDM at Peter Mac. Current research pursuits are novel PET tracers for breast cancer and the mechanisms behind the risk of increased breast density.
Dr Moodie will be talking on the role of imaging in the diagnosis and staging of Breast Cancer, with a particular focus on the role of PET/CT in this.
Wednesday 8 September 6:30pm AEST
Lymphoscintigraphy Technologist Panel: Competency, Colloids and More.
Speaker 1:
Melanie Tempest, Chief Nuclear Medicine Technologist, Western Health
Title of talk: Intradermal injections for breast sentinel node lymphoscintigraphy - Development of a training and competency-based assessment package for NMTs
Melanie completed her undergraduate degree at RMIT and spent the early years of her career at the Alfred. She then spent several years at Peter MacCallum Cancer Centre and before joining Western Health, where she has served as Chief NMT since 2009.
Speaker 2:
Kylie O’Halloran, Senior Nuclear Medicine Technologist, St Vincent’s Hospital, Melbourne.
Title of Talk: The Use of Local Anaesthetic in Breast Lymphoscintigraphy - The St Vincent's Experience
Kylie is a Senior Nuclear Medicine Technologist at St Vincent’s Hospital Melbourne. She has been in the role of Student and Intern Supervisor for a number of years and has completed a Masters of Quality Services (Health and Safety). She has a keen interest in the area of safe, equitable, high value healthcare and in recent years has been working in quality improvement at St Vincent’s Medical Imaging.
Speaker 3:
David Sheean, Lead Technologist, Nuclear Medicine, St Vincent’s Hospital, Melbourne.
Title of Talk: Lymphatic Radiopharmaceutical Review
David is a Senior Nuclear Medicine Technologist at St Vincent’s Hospital Melbourne. He has experience across many areas of Nuclear Medicine and has completed a Masters Degree in Public Health. David has particular interests in Radiopharmacy, Nuclear Medicine Therapy and Health Economics.